MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

Not even tempting Dartboard. If the results of phase 2b are...

  1. 142 Posts.
    Not even tempting Dartboard. If the results of phase 2b are similar to 2a, 1b and 1a then the sp will fly past $2.25.

    I have no idea what the results of the trial are but I do recognise trends when I see them. Unless they have altered the drug significantly since the phase 1 trials then I see no reason why the results of a large human trial wouldn't follow the same trend of previous smaller trials involving animals and humans.

    We'll know soon enough.

 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.